Treatment for the menopause in Central America: Use, knowledge, perceptions and attitudes among urban living middle-aged women

Gynecological Endocrinology

Volumn 27, Issue 7, 2011, Pages 504-511

  Tserotas, Konstantino ^a   Hernandez, Luis ^a   Morera, Flory ^b   Pineda, Ricardo ^c   Chedraui, Peter ^d  

^a Caja del Seguro Social ^*  (Guatemala)

^b UNIVERSIDAD DE COSTA RICA   (Costa Rica)

^c Vive Sin Temor Central American Public Relationship Campaign for the Right Knowledge Regarding HRT   (Costa Rica)

^d Instituto Para la Salud de la Mujer   (Ecuador)

Author keywords

attitude; Central America; compliance; hormone therapy; knowledge; Menopause; treatment

Indexed keywords

ESTROGEN; PHYTOESTROGEN;

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; CANCER RISK; DRUG USE; FEMALE; HEALTH CARE COST; HEALTH EDUCATION; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; PATIENT EDUCATION; PERCEPTION; PHYSICIAN; POSTMENOPAUSE; PRIORITY JOURNAL; RISK REDUCTION; SOCIAL STATUS; TREATMENT INDICATION; UNSPECIFIED SIDE EFFECT; URBAN AREA;

ADULT; AGED; CENTRAL AMERICA; CROSS-SECTIONAL STUDIES; ESTROGEN REPLACEMENT THERAPY; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MENOPAUSE; MIDDLE AGED; QUESTIONNAIRES; URBAN POPULATION; WOMEN; WOMEN'S HEALTH;

EID: 79958031522     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2010.495798     Document Type: Article

References (50)

1. Castelo-Branco C, Vicente JJ, Figueras F, Sanjuan A, Martinez de Osaba MJ, Casals E, Pons F, Balasch J, Vanrell JA. Comparative effects of estrogens plus androgens and tibolone on bone, lipid pattern and sexuality in postmenopausal women. Maturitas 2000;34:161-168. (Pubitemid 30068655)
2. Castelo-Branco C, Cancelo MJ, Villero J, Nohales F, Julia MD. Management of post-menopausal vaginal atrophy and atrophic vaginitis. Maturitas 2005;52:S46-S52. (Pubitemid 41630619)
3. Castelo-Branco C, Rostro F. Management of menopause. Minerva Ginecol 2006;58:137-152. (Pubitemid 43724811)
4. Castelo-Branco C, Palacios S, Calaf J, Vazquez F, Lanchares JL. Available medical choices for the management of menopause. Maturitas 2005;52:S61-S70. (Pubitemid 41625567)
5. Blumel JE, Castelo-Branco C, Leal T, Gallardo L, Saini J, Ferron S, Haya J. Effects of transdermal estrogens on endothelial function in postmenopausal women with coronary disease. Climacteric 2003;6:38-44. (Pubitemid 36398871)
6. Castelo-Branco C, Duran M, PuigM, Vanrell JA. Compliance with hormone replacement therapy at the menopause. J Obstet Gynaecol 1995;15:204-205.
7. Castelo-Branco C, Figueras F, Sanjuan A, Vicente JJ, Martinez de Osaba MJ, Pons F, Balasch J, Vanrell JA. Longterm compliance with estrogen replacement therapy in surgical postmenopausal women: benefits to bone and analysis of factors associated with discontinuation. Menopause 1999;6: 307-311. (Pubitemid 30003273)
8. Blumel JE, Castelo-Branco C, Riquelme R, Araya H, Jaramillo P, Tacla X, Colodron M, Lavin P. Use of hormone replacement therapy among Chilean women: a comparison between socioeconomic levels. Menopause 2002;9:377-380. (Pubitemid 36701898)
9. Bianco V, Murina F, Roberti P, Valente I. Tibolone in the treatment of menopause: compliance, efficacy and safety in a ten year experience. Minerva Ginecol 2006;58: 335-344. (Pubitemid 44476709)
10. Castelo-Branco C, Ferrer J, Palacios S, Cornago S, Peralta S. Spanish post-menopausal women's viewpoints on hormone therapy. Maturitas 2007;56:420-428. (Pubitemid 46420499)
11. Leon-Leon P, Chedraui P, Hidalgo L, Ortiz F, Castelo- Branco C. Hormone therapy for the management of the menopause in Ecuador: perception, use and knowledge among middle aged women. Gynecol Endocrinol 2008;24: 580-585.
12. Castelo-Branco C, Peralta S, Ferrer J, Palacios S, Cornago S, Quereda F. The dilemma of menopause and hormone replacement - a challenge for women and health-care providers: knowledge of menopause and hormone therapy in Spanish menopausal women. Climacteric 2006;9:380-387. (Pubitemid 44454529)
13. Shmuely Y, Berlin JA, Knauss J, Lydick E. Compliance with oral HRT in postmenopausal women in clinical trials - meta analysis. Maturitas 2003;46:33-44. (Pubitemid 37088130)
14. Wattanakumtornkul S, Chichareon S, Geater A, Suwan K. Compliance with hormone replacement therapy at Songklanagarind Hospital. J Obstet Gynaecol Res 2003;29: 380-387. (Pubitemid 38180674)
15. Ferguson KJ, Hoegh C, Johnson S. Estrogen replacement therapy. A survey of women's knowledge and attitudes. Arch Intern Med 1989;149:133-136. (Pubitemid 19036829)
16. Corrado F, D'Anna R, Caputo F, Cannata ML, Zoccali MG, Cancellieri F. Compliance with hormone replacement therapy in postmenopausal Sicilian women. Eur J Obstet Gynecol Reprod Biol 2005;118:225-228. (Pubitemid 40093839)
17. Yasui T, Uemura H, Takikawa M, Irahara M. Hormone replacement therapy in postmenopausal women. J Med Invest 2003;50:136-145. (Pubitemid 38019760)
18. Hara Y, Shintani M. Compliance of hormone replacement therapy in postmenopausal women in Japan. Nippon Rinsho 2004;62:496-500.
19. Lindh-Astrand L, Brynhildsen J, Hoffmann M, Liffner S, Hammar M. Attitudes towards the menopause and hormone therapy over the turn of the century. Maturitas 2007;56: 12-20. (Pubitemid 44894785)
20. Ekstrom H. Trends in middle-aged women's reports of symptoms, use of hormone therapy and attitudes towards it. Maturitas 2005;52:154-164. (Pubitemid 41368038)
21. Blumel JE, Castelo-Branco C, Chedraui PA, Binfa L, Dowlani B, Gomez MS, Sarra S. Patients' and clinicians' attitudes after the Women's Health Initiative study. Menopause 2004;11: 57-61. (Pubitemid 40362199)
22. Hoffmann M, Hammar M, Kjellgren KI, Lindh-Astrand L, Brynhildsen J. Changes in women's attitudes towards and use of hormone therapy after HERS and WHI. Maturitas 2005;52:11-17. (Pubitemid 41242737)
23. Power ML, Zinberg S, Schulkin J. A survey of obstetriciangynecologists concerning practice patterns and attitudes toward hormone therapy. Menopause 2006;13:434-441.
24. Travers C, O'Neill SM, Khoo SK, King R. Hormones down under: hormone therapy use after the Women's Health Initiative. Aust N Z J Obstet Gynaecol 2006;46:330-335. (Pubitemid 43984952)
25. Kang BM, Kim MR, Park HM, Yoon BK, Lee BS, Chung HW, Cho SH, Choi H, Kim JG. Attitudes of Korean clinicians to postmenopausal hormone therapy after the Women's Health Initiative study. Menopause 2006;13:125-129.
26. Lazar F Jr, Costa-Paiva L, Morais SS, Pedro AO, Pinto-Neto AM. The attitude of gynecologists in Sao Paulo, Brazil 3 years after the Women's Health Initiative study. Maturitas 2007;56: 129-141. (Pubitemid 46073511)
27. Gerend MA, Aiken LS, Erchull MJ, Lapin A. Women's use of hormone therapy before and after the Women's Health Initiative: a psychosocial model of stability and change. Prev Med 2006;43:158-164. (Pubitemid 44331311)
28. Longworth JC. Hispanic women's experience with "el cambio de vida". J Am Acad Nurse Pract 2003;15:266-275.
29. Castelo-Branco C, Blumel JE, Chedraui P, Calle A, Bocanera R, Depiano E, Figueroa-Casas P, Gonzalez C, Martino M, Royer M, et al. . Age at menopause in Latin America. Menopause 2006;13:706-712. (Pubitemid 44079541)
30. Leon P, Chedraui P, Hidalgo L, Ortiz F. Perceptions and attitudes toward the menopause among middle aged women from Guayaquil, Ecuador. Maturitas 2007;57:233-238. (Pubitemid 46891696)
31. Gavin NI, Thorp JM, Ohsfeldt RL. Determinants of hormone replacement therapy duration among postmenopausal women with intact uteri. Menopause 2001;8:377-383. (Pubitemid 32826172)
32. Sturdee DW. The importance of patient education in improving compliance. Climacteric 2000;3:9-13. (Pubitemid 32448490)
33. Eiken P, Kolthoff N. Compliance with 10 years oral hormonal replacement therapy. Maturitas 2002;41:81-86. (Pubitemid 34142496)
34. Griffiths F. Women's health concerns. Is the promotion of hormone replacement therapy for prevention important to women? Fam Pract 1995;12:54-59.
35. Huang KE, Xu L, I NN, Jaisamrarn U. The Asian Menopause Survey: knowledge, perceptions, hormone treatment and sexual function. Maturitas 2010;65:276-283.
36. Carney PA, Tosteson AN, Titus-Ernstoff L, Weiss JE, Goodrich ME, Manganiello P, Kasales CJ. Hormone therapies in women aged 40 and older: prevalence and correlates of use. Maturitas 2006;53:65-76. (Pubitemid 41736061)
37. Olesen AV, Johnsen SP, Mortensen JT, Boggild H, Olsen J, Sorensen HT. Socioeconomic status and use of postmenopausal hormone replacement therapy among Danish women. Acta Obstet Gynecol Scand 2005;84:639-644. (Pubitemid 40917386)
38. Donker GA, Spreeuwenberg P, Bartelds AI, van der Velden K, Foets M. Hormone replacement therapy: changes in frequency and type of prescription by Dutch GPs during the last decade of the millennium. Fam Pract 2000;17:508-513. (Pubitemid 32040836)
39. Castelo-Branco C, Ferrer J, Palacios S, Cornago S. The prescription of hormone replacement therapy in Spain: differences between general practitioners and gynaecologists. Maturitas 2006;55:308-316. (Pubitemid 44693068)
40. Bermejo MJ, Perez IR. Physicians and the prescription of hormone replacement therapy in Spain. Health Policy 2005;73:58-65. (Pubitemid 40724953)
41. Barbaglia G, Macià F, Comas M, Sala M, del Mar Vernet M, Casamitjana M, Castells X. Trends in hormone therapy use before and after publication of the Women's Health Initiative trial: 10 years of follow-up. Menopause 2009;16: 1061-1064.
42. Chedraui P, Blümel JE, Baron G, Belzares E, Bencosme A, Calle A, Danckers L, Espinoza MT, Flores D, Gomez G, et al. Impaired quality of life among middle aged women: a multicentre Latin American study. Maturitas 2008;61:323-329.
43. Beral V, Banks E, Reeves G, Appleby P. Use of HRT and the subsequent risk of cancer. J Epidemiol Biostat 1999;4:191-210.
44. Armstrong K, Popik S, Guerra C, Ubel PA. Beliefs about breast cancer risk and use of postmenopausal hormone replacement therapy. Med Decis Making 2000;20: 308-313. (Pubitemid 30470726)
45. Sommer B, Avis N, Meyer P, Ory M, Madden T, Kagawa- Singer M, Mouton C, Rasor NO, Adler S. Attitudes toward menopause and aging across ethnic/racial groups. Psychosom Med 1999;61:868-875.
46. Avis NE, Assmann SF, Kravitz HM, Ganz PA, Ory M. Quality of life in diverse groups of midlife women: assessing the influence of menopause, health status and psychosocial and demographic factors. Qual Life Res 2004;13:933-946. (Pubitemid 39005103)
47. Gold EB, Bair Y, Zhang G, Utts J, Greendale GA, Upchurch D, Chyu L, Sternfeld B, Adler S. Cross-sectional analysis of specific complementary and alternative medicine (CAM) use by racial/ethnic group and menopausal status: the Study of Women's Health Across the Nation (SWAN). Menopause 2007;14:612-623. (Pubitemid 47051953)
48. Nassar AH, Abd Essamad HM, Awwad JT, Khoury NG, Usta IM. Gynecologists' attitudes towards hormone therapy in the post "Women's Health Initiative" study era. Maturitas 2005;52:18-25. (Pubitemid 41242738)
49. Coombs NJ, Cronin KA, Taylor RJ, Freedman AN, Boyages J. The impact of changes in hormone therapy on breast cancer incidence in the US population. Cancer Causes Control 2010;21:83-90.
50. Chlebowski RT. Menopausal hormone therapy, hormone receptor status, and lung cancer in women. Semin Oncol 2009;36:566-571.